Drug manufacturer Sanofi recently started denying access for some health centers to 340B pricing at contract pharmacies after previously saying [...] …
Category: Pharma Industry
Drug manufacturer Merck recently announced that it owes refunds to 340B covered entities for purchases of 17 products during the [...] …
Inaccurate points were ascribed to 340B advisers and service providers in a recent legal filing by four drugmakers as part [...] …
Drug manufacturer Janssen Biotech recently determined that it owes or may owe refunds to some 340B covered entities. The refunds [...] …
The drug industry group challenging the legality of Arkansas’ 340B contract pharmacy law, notified a federal appeals court that the [...] …
Drug manufacturer Tolmar recently said it plans refunds to 340B covered entities for overcharges on seven generic dermatologic products purchased [...] …
Belgium drug maker UCB will add restrictions on 340B contract pharmacy use for hospitals starting Oct. 2, according to a [...] …
Drug manufacturer EMD Serono (EMDS) today announced 340B contract pharmacy restrictions for hospitals will expand Oct. 1 to all of [...] …
The Arkansas Insurance Department (AID) has formally notified at least four drugmakers that they are in potential violation of a [...] …
Drug maker Boehringer Ingelheim (BI) sued the federal government to block Medicare price negotiations shortly before the Department of Health [...] …